A pioneering test which reliably predicts the spread or return of the most deadly form of skin cancer has been developed by a team of Newcastle scientists and clinicians.
A pioneering test which reliably predicts the spread or return of the most deadly form of skin cancer has been developed by a team of Newcastle scientists and clinicians.
The technological advance came as they made a scientific breakthrough in understanding the mechanism of skin cancer growth.
Led by Professor Penny Lovat at Newcastle University, UK, in association with the University spin out company AMLo Biosciences, the test offers reassurance for patients diagnosed with an early stage melanoma.
By applying the test - called AMBLor® - to the standard biopsy of the primary melanoma on its removal, patients who are at low risk of the disease reoccurring or spreading can be identified.
Read more at Newcastle University
Image: Penny Lovat, Professor of Cellular Dermatology and Oncology at Newcastle University and Chief Scientific Officer at AMLo Biosciences (Credit: Newcastle University)
